These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21724445)

  • 21. Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis.
    Shaarawy M; Abassi AF; Hassan H; Salem ME
    Fertil Steril; 2003 Apr; 79(4):919-24. PubMed ID: 12749431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of bone turnover markers in clinical practice.
    Biver E
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):468-73. PubMed ID: 23128576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
    Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
    Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods.
    Wang J; Yan D; Zhao A; Hou X; Zheng X; Chen P; Bao Y; Jia W; Hu C; Zhang ZL; Jia W
    Osteoporos Int; 2019 Jul; 30(7):1491-1499. PubMed ID: 30778642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Claustrat B; Delmas PD
    J Bone Miner Res; 2000 Aug; 15(8):1526-36. PubMed ID: 10934651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.
    Costa AG; Walker MD; Zhang CA; Cremers S; Dworakowski E; McMahon DJ; Liu G; Bilezikian JP
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4736-43. PubMed ID: 24037879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.
    Bruyere O; Collette J; Delmas P; Rouillon A; Roux C; Seidel L; Richy F; Reginster JY
    Maturitas; 2003 Apr; 44(4):259-65. PubMed ID: 12697366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
    Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum microRNAs as novel biomarkers for osteoporotic vertebral fractures.
    Zarecki P; Hackl M; Grillari J; Debono M; Eastell R
    Bone; 2020 Jan; 130():115105. PubMed ID: 31669252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
    Lai PS; Chua SS; Chew YY; Chan SP
    J Clin Pharm Ther; 2011 Oct; 36(5):557-67. PubMed ID: 21916908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone Turnover Markers for Osteoporosis Status Assessment at Baseline in Postmenopausal Pakistani Females.
    Naeem ST; Hussain R; Raheem A; Siddiqui I; Ghani F; Khan AH
    J Coll Physicians Surg Pak; 2016 May; 26(5):408-12. PubMed ID: 27225148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
    J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?
    Chavassieux P; Portero-Muzy N; Roux JP; Garnero P; Chapurlat R
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4662-8. PubMed ID: 26505821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
    Vasikaran S; Eastell R; Bruyère O; Foldes AJ; Garnero P; Griesmacher A; McClung M; Morris HA; Silverman S; Trenti T; Wahl DA; Cooper C; Kanis JA;
    Osteoporos Int; 2011 Feb; 22(2):391-420. PubMed ID: 21184054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis.
    Eastell R; Reid DM; Vukicevic S; Ensrud KE; LaCroix AZ; Thompson JR; Thompson DD; Cummings SR
    Bone; 2012 May; 50(5):1135-40. PubMed ID: 22348983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of Migu tablet on bone mineral density, serum matrix metalloproteinase-2 level and bone metabolic markers in postmenopausal osteoporosis].
    Dai Y; Shen L
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2409-12. PubMed ID: 18257271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Iki M; Morita A; Ikeda Y; Sato Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2006; 17(7):1086-95. PubMed ID: 16758145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between dental panoramic radiographic findings and biochemical markers of bone turnover.
    Taguchi A; Sanada M; Krall E; Nakamoto T; Ohtsuka M; Suei Y; Tanimoto K; Kodama I; Tsuda M; Ohama K
    J Bone Miner Res; 2003 Sep; 18(9):1689-94. PubMed ID: 12968679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-telopeptides of type I collagen in postmenopausal women: an experience in a Tunisian clinical laboratory.
    Bouzid K; Bahlous A; Kalaï E; Fellah H; Sahli H; Sellami S; Abdelmoula J
    Tunis Med; 2010 Jul; 88(7):467-9. PubMed ID: 20582880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.